Discovery of Novel Tricyclic Full Agonists for the G-Protein-Coupled Niacin Receptor 109A with Minimized Flushing in Rats
Hong C. Shen(Roche (China)), Steven L. Colletti(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ning Ren(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ester Carballo‐Jane(Merck & Co., Inc., Rahway, NJ, USA (United States)), James R. Tata(Merck & Co., Inc., Rahway, NJ, USA (United States)), Tsuei-Ju Wu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Andrew K.P. Taggart(Merck & Co., Inc., Rahway, NJ, USA (United States)), Qing Chen(Queensland University of Technology), M. Gerard Waters(Merck & Co., Inc., Rahway, NJ, USA (United States)), Tom G. Holt(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mihajlo L. Krsmanovic(Merck & Co., Inc., Rahway, NJ, USA (United States)), Milton L. Hammond(Merck & Co., Inc., Rahway, NJ, USA (United States)), Qiaolin Deng(Karolinska Institutet), Kang Cheng(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kenneth K. Wu(National Health Research Institutes), Michael S. Wolff(Merck & Co., Inc., Rahway, NJ, USA (United States)), Tian‐Quan Cai(Merck & Co., Inc., Rahway, NJ, USA (United States)), Larissa Wilsie(Merck & Co., Inc., Rahway, NJ, USA (United States)), Xinchun Tong(Merck & Co., Inc., Rahway, NJ, USA (United States)), Fa‐Xiang Ding(MACOM (United States))
Cited by 80
Related Papers
Recent advances in syntheses of heterocycles and carbocycles via homogeneous gold catalysis. Part 1: Heteroatom addition and hydroarylation reactions of alkynes, allenes, and alkenes
|Tetrahedron|2008|521
Adenovirus-Mediated Heme Oxygenase-1 Gene Transfer Inhibits the Development of Atherosclerosis in Apolipoprotein E–Deficient Mice
|Circulation|2001|331
Recent advances in syntheses of carbocycles and heterocycles via homogeneous gold catalysis. Part 2: Cyclizations and cycloadditions
|Tetrahedron|2008|322
Ruthenium-Catalyzed Intramolecular [5 + 2] Cycloadditions
|Journal of the American Chemical Society|2000|237